AN2 Therapeutics (ANTX) Non-Current Assets (2021 - 2026)
AN2 Therapeutics (ANTX) recorded Non-Current Assets of $1.69 million in Q2 2026, down 79.7% from $8.3 million a year earlier.
Powered by 
Analysis
AN2 Therapeutics (ANTX) Non-Current Assets (2021 - 2026) Analysis & Trends
At the end of FY2025, AN2 Therapeutics reported Non-Current Assets of $2.01 million, down 65.4% from FY2024.
- Annual Non-Current Assets has a four-year compound annual growth rate of -21.2% (FY2021 to FY2025).
- Across earlier years, Non-Current Assets came in at $5.83 million in FY2024 (-79.4%), $28.24 million in FY2023 (+616.9%), $3.94 million in FY2022 (-24.4%) and $5.21 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Non-Current Assets since Q2 2024.
- On a year-over-year basis, Non-Current Assets rose in two of the last five quarters, with growth averaging 121.9%.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 910.3% in Q3 2023, against a decline of 79.7% in Q2 2026 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 159.99 Bn |
| 10 | AN2 Therapeutics | 164.30 Mn | -121.79 Mn | - | 16.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 16.19 Mn |
| Jun 30, 2026 | 1.69 Mn |
| Dec 31, 2025 | 2.01 Mn |
| Sep 30, 2025 | 3.22 Mn |
| Jun 30, 2025 | 8.30 Mn |
| Mar 31, 2025 | 11.78 Mn |
| Dec 31, 2024 | 5.83 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 4.95 Mn |
| Dec 31, 2023 | 28.24 Mn |
| Sep 30, 2023 | 27.40 Mn |
| Jun 30, 2023 | 720,000.00 |
| Mar 31, 2023 | 768,000.00 |
| Dec 31, 2022 | 3.94 Mn |
| Sep 30, 2022 | 2.71 Mn |
| Jun 30, 2022 | 3.14 Mn |
| Mar 31, 2022 | 720,000.00 |
| Dec 31, 2021 | 5.21 Mn |
API Access
AN2 Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ANTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ANTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ANTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();